Abevmy 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
IB/0022 
B.II.f.1.a.1 - Stability of FP - Reduction of the shelf 
31/01/2024 
SmPC 
life of the finished product - As packaged for sale 
IAIN/0021 
B.II.b.2.c.1 - Change to importer, batch release 
29/11/2023 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
Annex II and 
PL 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
responsible for importation and/or batch release - 
Not including batch control/testing 
T/0019 
Transfer of Marketing Authorisation 
03/08/2023 
30/08/2023 
SmPC, 
Labelling and 
PL 
IB/0018 
B.I.b.2.a - Change in test procedure for AS or 
20/07/2023 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0017 
B.II.b.5.z - Change to in-process tests or limits 
03/02/2023 
n/a 
applied during the manufacture of the finished 
product - Other variation 
PSUSA/403/2
Periodic Safety Update EU Single assessment - 
13/10/2022 
09/12/2022 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
02202 
bevacizumab 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/403/202202. 
IB/0016 
B.II.b.4.f - Change in the batch size (including batch 
06/12/2022 
n/a 
size ranges) of the finished product - The scale for a 
biological/immunological medicinal product is 
increased/decreased without process change (e.g. 
duplication of line) 
IB/0015/G 
This was an application for a group of variations. 
06/10/2022 
n/a 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
Page 2/8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
finished product - Other variation 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
B.II.e.3.c - Change in test procedure for the 
immediate packaging of the finished product - 
Deletion of a test procedure if an alternative test 
procedure is already authorised 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
B.II.e.2.a - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Tightening of specification limits 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
B.II.e.3.c - Change in test procedure for the 
immediate packaging of the finished product - 
Deletion of a test procedure if an alternative test 
procedure is already authorised 
B.II.e.2.c - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Deletion of a non-significant 
specification parameter (e.g. deletion of an obsolete 
parameter) 
B.II.e.2.c - Change in the specification parameters 
and/or limits of the immediate packaging of the 
Page 3/8 
 
 
 
 
 
finished product - Deletion of a non-significant 
specification parameter (e.g. deletion of an obsolete 
parameter) 
B.II.e.2.c - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Deletion of a non-significant 
specification parameter (e.g. deletion of an obsolete 
parameter) 
B.II.e.7.a - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Deletion of a supplier 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
Page 4/8 
 
 
 
 
 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
B.II.e.z - Change in container closure system of the 
Finished Product - Other variation 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
B.II.e.3.c - Change in test procedure for the 
immediate packaging of the finished product - 
Deletion of a test procedure if an alternative test 
procedure is already authorised 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
B.II.e.2.a - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Tightening of specification limits 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
Page 5/8 
 
 
 
 
 
 
IB/0014 
C.I.2.a - Change in the SPC, Labelling or PL of a 
23/08/2022 
09/12/2022 
SmPC and PL 
Sections 4.2 and 6.6 of the SmPC have been updated to 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
IB/0013/G 
This was an application for a group of variations. 
26/07/2022 
n/a 
add the wording “Do not shake vial” following 
reinstatement of the same wording in the PI of the 
reference product. The PL has been updated accordingly. 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
IB/0011 
B.I.a.2.a - Changes in the manufacturing process of 
19/07/2022 
n/a 
the AS - Minor change in the manufacturing process 
of the AS 
IAIN/0012 
B.II.b.1.a - Replacement or addition of a 
20/06/2022 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
IB/0008 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
11/04/2022 
09/12/2022 
SmPC and PL 
life of the finished product - As packaged for sale 
(supported by real time data) 
IA/0007/G 
This was an application for a group of variations. 
18/02/2022 
09/12/2022 
Annex II 
A.5.b - Administrative change - Change in the name 
Page 6/8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
II/0005/G 
This was an application for a group of variations. 
13/01/2022 
n/a 
B.II.g.2 - Introduction of a post approval change 
management protocol related to the finished product 
B.I.e.2 - Introduction of a post approval change 
management protocol related to the AS 
IB/0006 
B.II.f.1.b.3 - Stability of FP - Extension of the shelf 
08/12/2021 
09/12/2022 
SmPC and PL 
life of the finished product - After dilution or 
reconstitution (supported by real time data) 
IB/0004 
B.I.b.2.e - Change in test procedure for AS or 
03/08/2021 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
IB/0003/G 
This was an application for a group of variations. 
30/07/2021 
n/a 
Page 7/8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
B.I.b.1.z - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
IB/0001 
B.I.b.2.c - Change in test procedure for AS or 
29/07/2021 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
Page 8/8 
 
 
 
 
 
 
 
 
 
 
